A novel role of DNA polymerase η in modulating cellular sensitivity to chemotherapeutic agents

Molecular Cancer Research

Volumn 4, Issue 4, 2006, Pages 257-265

  Chen, Yih Wen ^a   Cleaver, James E ^b   Hanaoka, Fumio ^c   Chang, Ching Fang ^a   Chou, Kai Ming ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA DEXTRO ARABINOFURANOSYLCYTOSINE; CAMPTOTHECIN; CISPLATIN; CYTARABINE; DNA DIRECTED DNA POLYMERASE ETA; GEMCITABINE; NUCLEOTIDYLTRANSFERASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CELLULAR DISTRIBUTION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; DOWN REGULATION; DRUG INHIBITION; DRUG SENSITIVITY; FIBROBLAST; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

ANTINEOPLASTIC AGENTS; DNA; DNA REPLICATION; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, NEOPLASM; FIBROBLASTS; HUMANS; NUCLEOSIDES; PROLIFERATING CELL NUCLEAR ANTIGEN; XERODERMA PIGMENTOSUM;

EID: 33646158472     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-05-0118     Document Type: Article

References (32)

1. Masutani C, Kusumoto R, Yamada A, et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η. Nature 1999;399:700-4.
2. O'Day CL, Burgers PM, Taylor JS. PCNA-induced DNA synthesis past cis-syn and trans-syn-I thymine dimers by calf thymus DNA polymerase δ in vitro. Nucleic Acids Res 1992;20:5403-6.
3. Kusumoto R, Masutani C, Iwai S, Hanaoka F. Translesion synthesis by human DNA polymerase η across thymine glycol lesions. Biochemistry 2002;41:6090-9.
4. Trincao J, Johnson RE, Escalante CR, Prakash S, Prakash L, Aggarwal AK. Structure of the catalytic core of S. cerevisiae DNA polymerase η: implications for translesion DNA synthesis. Mol Cell 2001;8:417-26.
5. Sampath D, Rao VA, Plunkett W. Mechanisms of apoptosis induction by nuclcoside analogs. Oncogene 2003;22:9063-74.
6. Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res 1991;51:6110-7.
7. Kukhanova M, Liu SH, Mozzherin D, Lin TS, Chu CK, Cheng YC. L- and D-Enantiomers of 2′,3′-dideoxycytidine 5′-triphosphate analogs as substrates for human DNA polymerases. Implications for the mechanism of toxicity. J Biol Chem 1995;270:23055-9.
8. Siddik ZH. Biochemical and molecular mechanisms of cisplatin resistance. Cancer Treat Res 2002;112:263-84.
9. Crul M, van Waardenburg RC, Bocxe S, et al. DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin. Biochem Pharmacol 2003;65:275-82.
10. Crul M, van Waardenburg RC, Beijnen JH, Schellens JH. DNA-based drug interactions of cisplatin. Cancer Treat Rev 2002;28:291-303.
11. Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ. Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol 1995;22:72-9.
12. Vaisman A, Masutani C, Hanaoka F, Chaney SG. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase η. Biochemistry 2000;39:4575-80.
13. Chaney SG, Campbell SL, Bassett E, Wu Y. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. Crit Rev Oncol Hematol 2005;53:3-11.
14. Yamada K, Takezawa J, Ezaki O. Translesion replication in cisplatin-treated xeroderma pigmentosum variant cells is also caffeine-sensitive: features of the error-prone DNA polymerase(s) involved in UV-mutagenesis. DNA Repair (Amst) 2003;2:909-24.
15. Cleaver JE, Afzal V, Feeney L, et al. Increased ultraviolet sensitivity and chromosomal instability related to p53 function in the xeroderma pigmentosum variant. Cancer Res 1999;59:1102-8.
16. Albertella MR, Green CM, Lehmann AR, O'Connor MJ. A role for polymerase η in the cellular tolerance to cisplatin-induced damage. Cancer Res 2005;65:9799-806.
17. Pommier Y. Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints. Curr Med Chem Anti-Canc Agents 2004;4:429-34.
18. Mutch DG. Gemcitabine combination chemotherapy of ovarian cancer. Gynecol Oncol 2003;90:S16-20.
19. Laposa RR, Feeney L, Cleaver JE. Recapitulation of the cellular xeroderma pigmentosum-variant phenotypes using short interfering RNA for DNA polymerase H. Cancer Res 2003;63:3909-12.
20. Thakur M, Wernick M, Collins C, Limoli CL, Crowley E, Cleaver JE. DNA polymerase η undergoes alternative splicing, protects against UV sensitivity and apoptosis, and suppresses Mre11-dependent recombination. Genes Chromosomes Cancer 2001;32:222-35.
21. Kannouche PL, Wing J, Lehmann AR. Interaction of human DNA polymerase η with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol Cell 2004;14:491-500.
22. Chou KM, Kukhanova M, Cheng YC. A novel action of human apurinic/ apyrimidinic endonuclease: excision of L-configuration deoxyribonucleoside analogs from the 3′ termini of DNA. J Biol Chem 2000;275:31009-15.
23. Gmeiner WH, Skradis A, Pon RT, Liu J. Cytarabine-induced destabilization of a model Okazaki fragment. Nucleic Acids Res 1998;26:2359-65.
24. Gmeiner WH. Antimetabolite incorporation into DNA: structural and thermodynamic basis for anticancer activity. Biopolymers 2002;65:180-9.
25. Mikita T, Beardsley GP. Functional consequences of the arabinosylcytosine structural lesion in DNA. Biochemistry 1988;27:4698-705.
26. Beardsley GP, Mikita T, Klaus MM, Nussbaum AL. Chemical synthesis of DNA oligomers containing cytosine arabinoside. Nucleic Acids Res 1988;16:9165-76.
27. Bassett E, King NM, Bryant MF, et al. The role of DNA polymerase η in translesion synthesis past platinum-DNA adducts in human fibroblasts. Cancer Res 2004;64:6469-75.
28. Andrews PA, Velury S, Mann SC, Howell SB. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 1988;48:68-73.
29. Cleaver JE. Sensitivity of excision repair in normal human, xeroderma pigmentosum variant and Cockayne's syndrome fibroblasts to inhibition by cytosine arabinoside. J Cell Physiol 1981;108:163-73.
30. Dingman CW, Kakunaga T. DNA strand breaking and rejoining in response to ultraviolet light in normal human and xeroderma pigmemosum cells. Int J Radiat Biol Relat Stud Phys Chem Med 1976;30:55-66.
31. Masutani C, Kusumoto R, Iwai S, Hanaoka F. Mechanisms of accurate translesion synthesis by human DNA polymerase η. EMBO J 2000;19:3100-9.
32. 6-methylguanine lesions in DNA: contrasting responses from the "bypass" DNA polymerase η and the replicative DNA polymerase α. Chem Res Toxicol 2003;16:1616-23.